MedTrace Logo

Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-infected Patients

NCT00647244 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2010-12-20

No results posted yet for this study

Summary

To evaluate the efficacy and safety of switching from Retrovir to Tenofovir or Abacavir in HIV-infected patients

Conditions

  • HIV Infections

Interventions

DRUG

Tenofovir disoproxil fumarate

Tenofovir disoproxil 245 mg oral tablet once daily

DRUG

Abacavir

Abacavir 300 mg oral tablet twice daily

Sponsors & Collaborators

  • Aarhus University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • Denmark

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00647244 on ClinicalTrials.gov